• <table id="gigg0"></table>
  • west china medical publishers
    Author
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Author "Yuezhong ZHENG Jichuan SHI" 3 results
    • Clinical features and treatment of intermediate uveitis

      Objective To observe the clinical features, the complications and treatment effects of intermediate uveitis. Methods The clinical data of 36 patients (66 eyes) with intermediate uveitis were retrospectively analyzed,including the clinical features, fundus fluorescein angiography (FFA) features, complications,treatment effects and prognosis. The patients, 21 males and 15 females, aged from 8 to 70 years,with the mean age of 34.8 years. There were 30 cases with bilateral lesions and 6 cases with unilateral lesions. Results The main clinical manifestation were vitreous opacity, peripheral retinal venous lesions, optic disc edema, macular edema and posterior subcapsular cataract. The results of FFA showed that peripheral retinal venous lesions, optic disc hyperfluorescence, cystoid macular edema and retinal vein staining. After the treatment, the visual acuity of 31 cases(60 eyes,90.9%) were improved, 4 cases(5 eyes,7.6%) were stable and 1 case(1 eye,1.5%) was worsening. The main complications were cystoid macular edema, posterior subcapsular cataract and vitreous hemorrhage which leads to visual damage. Conclusions Intermediate uveitis was a common bilateral and chronic progressive intraocular inflammation,the anterior vitritis, pars plana and peripheral retinal vascular changes were mainly involved. Early diagnosis and proper treatment may prevent the permanent visual damage. 

      Release date:2016-09-02 05:46 Export PDF Favorites Scan
    • 葡萄膜炎的生物治療進展

      葡萄膜炎的發生與CD4+T細胞介導的自身免疫功能異常有關,糖皮質激素和免疫抑制劑是治療葡萄膜炎的主要藥物,這些藥物有著嚴重的毒副作用。利用單克隆抗體等生物制劑拮抗或封閉與疾病相關的淋巴細胞、細胞因子或細胞因子受體,可以達到治療葡萄膜炎的目的。這類生物制劑主要包括抗腫瘤壞死因子制劑、干擾素、白細胞介素受體拮抗劑、細胞毒T細胞相關抗原-4融合蛋白和CD20嵌合性單克隆抗體。生物治療為頑固性葡萄膜炎患者的治療帶來了希望,但是臨床觀察病例數較少,缺乏隨機化臨床試驗,這些制劑的適應證、治療劑量和治療時間均有待于進一步觀察。

      Release date:2016-09-02 05:46 Export PDF Favorites Scan
    • Measurement and significance of serum interferon-γ, tumor necrosis factor-α and interleukin-6 in patients with uveitis

      Objective To examine the levels of interferon-gamma; (INF-gamma;), tumor necrosis factor-alpha; (TNF-alpha;) and interleukin-6(IL-6) in serum of patients with acute uveitis before and after treatment, and to explore the possible roles of those cytokines in the initiation and progression of the uveitis. Methods A series of 75 patients with acute uveitis,and 30 healthy persons from our hospital were investigated. The levels of INF-gamma;, TNF-alpha; and IL-6 in acute phase and convalescent phase were measured by the enzymelinked immunosorbent assay. Result The serum levels of INF-gamma;, TNF-alpha; and IL-6 in acute phase were significantly higher than that of the convalescent phase and the healthy controls (F=65.805/50.418/155.381, P=0.000). A significant negative correlation was found between the serum levels of INF-gamma;, TNF-alpha; and IL-6 in acute phase with their initial visual acuity(r=-0.656, -0.592 and -0.653, Plt;0.01). There was also a positive correlation among the serum levels of INF-gamma;, TNF-alpha; and IL-6(r=0.340, 0.467 and 0.338, Plt;0.05). Conclusions There are high serum levels of INF-gamma;, TNF-alpha; and IL-6 in patients with acute uveitis, and the cytokines levels were decreased after the treatment. The results suggested that the INF-gamma;, TNF-alpha; and IL-6 involved in initiation and progression of uveitis. 

      Release date:2016-09-02 05:46 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南